Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nexgel (NXGL) EBITDA Margin (2018 - 2025)

Historic EBITDA Margin for Nexgel (NXGL) over the last 8 years, with Q3 2025 value amounting to 24.71%.

  • Nexgel's EBITDA Margin rose 20900.0% to 24.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 25.54%, marking a year-over-year increase of 329000.0%. This contributed to the annual value of 40.91% for FY2024, which is 441300.0% up from last year.
  • According to the latest figures from Q3 2025, Nexgel's EBITDA Margin is 24.71%, which was up 20900.0% from 22.05% recorded in Q2 2025.
  • In the past 5 years, Nexgel's EBITDA Margin ranged from a high of 22.05% in Q2 2025 and a low of 205.05% during Q1 2022
  • For the 5-year period, Nexgel's EBITDA Margin averaged around 101.83%, with its median value being 92.93% (2024).
  • Per our database at Business Quant, Nexgel's EBITDA Margin surged by 5028900bps in 2021 and then crashed by -102900bps in 2022.
  • Nexgel's EBITDA Margin (Quarter) stood at 166.42% in 2021, then fell by -10bps to 182.57% in 2022, then soared by 38bps to 112.66% in 2023, then surged by 75bps to 27.66% in 2024, then rose by 11bps to 24.71% in 2025.
  • Its last three reported values are 24.71% in Q3 2025, 22.05% for Q2 2025, and 27.69% during Q1 2025.